Emanuele de Rinaldis is the Global Head of Target, Diseases & Systems Biology (TDSB) at Sanofi, where he leads global teams to uncover novel therapeutic targets and advance drug discovery programs, combining high-throughput genomics analyses and AI/data analysis approaches. With over 25 years of leadership across academia, biotech, and pharma—including roles at Merck (US), King’s College (UK), Lion Bioscience (GE)—he has built and directed high-performing, cross-functional teams at the intersection of computational biology, translational science, and drug discovery. A recognized thought leader in the field, he has authored over 65 peer-reviewed publications in top-tier journals such as Nature Genetics, Immunity, and The Lancet.